3 iu dsip Dosage Chart – 10 mg Vial Protocol SS-31 | 50 mg -

Patients with the COMT gene polymorphism, COMTVal158Met, demonstrated a genetic predisposition for COMT hypomethylation and, thus, was the suggested reason for DR1 and DR2 hypermethylation

Side effects are typically mild and include injection site reactions or transient water retention

Always consult a qualified professional for questions about health or research use

In the trials not every participant advanced to the full 2.4 mg of each component, and dose flexibility was built into the design the target is reached gradually and not universally, so this is reference data describing the trial schedule, not a fixed prescription